Home »
Seven immune checkpoint inhibitors, targeting the PD-1, PD-L1, or CTLA-4 proteins, are currently approved for the treatment of cancer....
Surrounding a tumor is a vast network of blood vessels, immune cells, proteins, and even bacteria, all of which...
On December 23, 1971, when President Richard Nixon signed the National Cancer Act of 1971 into law, cancer was considered a death sentence. Only 42 percent of those diagnosed with cancer survived five years past diagnosis,...
Every cell in the human body contains about 300 million base pairs of double-stranded DNA that contribute to a...
“If our patients are diverse, why are clinical trials so white?” Vanessa Sheppard, PhD, invoked this quote from author and...
Due to advances in screening and treatment, the survival rate for patients with breast cancer has increased in recent decades. However, this progress...
Once considered undruggable, mutant KRAS has emerged in recent years as a viable target for anticancer therapeutics. As a...
Cancer is often described as a disease of old age, but over 15,000 children are diagnosed with cancer each...
What if a machine could “think” like a doctor and diagnose and treat a disease? This is one of the long-term goals for the...
This year marks the 10th anniversary of Cancer Discovery, a journal of the AACR. To celebrate the anniversary, Cancer Discovery published a special anniversary issue, featured spotlights on groundbreaking articles on its website, and held the Cancer Discovery ...